-+ 0.00%
-+ 0.00%
-+ 0.00%

Evercore ISI Group Maintains Outperform on AbbVie, Lowers Price Target to $235

Benzinga·05/15/2026 17:20:09
Listen to the news
Evercore ISI Group analyst Gavin Clark-Gartner maintains AbbVie (NYSE:ABBV) with a Outperform and lowers the price target from $236 to $235.